+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
HESTERBIO

Hester Biosciences Share Price

₹2,245.80 +38.1 (1.73%)
81.22% Gain from 52W Low

17 Sep, 2026 3:54 PM (IST)

Hester Biosciences live price: ₹2,245.80. It opened at ₹2,176 vs previous close ₹2,208; intraday high/low: ₹2,277/₹2,176. The 50 & 200 DMA stand at ₹2,290.20/₹2,001.00.

Hester Biosciences Performance

  • Today's Low
  • ₹2,176
  • Today's High
  • ₹2,277
  • 52 Week Low
  • ₹1,239
  • 52 Week High
  • ₹2,684
  • Open Price₹2,176
  • Previous Close₹2,208
  • Volume5,384
  • 50 DMA₹2,290.20
  • 100 DMA₹2,161.10
  • 200 DMA₹2,001.00

Hester Biosciences Chart

Investment Returns

  • Over 1 Month -6.98%
  • Over 3 Month + 9.32%
  • Over 6 Month + 55.97%
  • Over 1 Year + 8.86%

Smart Investing Starts Here Start SIP with Hester Biosciences for Steady Growth!

Invest Now

Hester Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 1,911
  • P/B Ratio
  • 4.2
  • Average True Range
  • 103.4
  • EPS
  • 160.1
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -37.5
  • RSI
  • 44.78
  • MFI
  • 71.58

Latest Stock News Updates

Hester Biosciences Ltd - 524669 - Shareholders' Approval For Reclassification From 'Promoter And Promoter Group' Category To 'Public' Category Shareholders

Shareholders'' approval for Reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public Category shareholders of the Company.

Hester Biosciences Ltd - 524669 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Scrutinizer''s Report for Postal Ballot Process

Hester Biosciences Ltd - 524669 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

Outcome, proceedings and Voting Results of Postal Ballot Process for the Notice dated 30 July 2026

Hester Biosciences Financials

Hester Biosciences Technicals

EMA & SMA

Current Price
₹2,245.80
+ 38.1 (1.73%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹2,294.80
  • 50 Day
  • ₹2,290.20
  • 100 Day
  • ₹2,161.10
  • 200 Day
  • ₹2,001.00

Resistance and Support

2232.9 Pivot Speed
  • R3 2,390.70
  • R2 2,333.80
  • R1 2,289.80
  • S1 2,188.90
  • S2 2,132.00
  • S3 2,088.00

Hester Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-30 Quarterly Results
2026-05-15 Audited Results & Final Dividend
2026-01-30 Quarterly Results
2025-11-12 Quarterly Results
2025-08-01 Quarterly Results
Date Purpose Remarks
2026-07-14 FINAL Rs.11.00 per share(110%)Final Dividend
2025-08-06 FINAL Rs.7.00 per share(70%)Final Dividend
View Hester Biosciences Dividend History Arrow

Hester Biosciences Shareholding Pattern

53.73%
45.95%
0.31%
0%

About Hester Biosciences

Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products. The Company has two principal operating and reporting segments viz. Poultry healthcare and Animal healthcare. View More
  • NSE Symbol
  • HESTERBIO
  • BSE Symbol
  • 524669
  • Executive Director,Managing Director,Chief Executive Officer
  • Rajiv D Gandhi
  • ISIN
  • INE782E01017

Similar Stocks to Hester Biosciences

Hester Biosciences FAQs

Hester Biosciences share price is ₹2,245 As on 17 September, 2026 | 23:17

The Market Cap of Hester Biosciences is ₹1910.5 Cr As on 17 September, 2026 | 23:17

The P/E ratio of Hester Biosciences is 14 As on 17 September, 2026 | 23:17

The PB ratio of Hester Biosciences is 4.2 As on 17 September, 2026 | 23:17

The 52 week High & Low of Hester Biosciences is ₹2683.6/₹1239.3 respectively As on 17 September, 2026 | 23:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23